Skip to content

Pressure titration offered by electrical impedance tomography-guided ventilation in intubated children with respiratory failure

Positive end-expiratory pressure titration guided by electrical impedance tomography vs. clinical titration in children with Hypoxemic Acute Respiratory Insufficiency : a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4ywf4tk
Enrollment
Unknown
Registered
2023-06-16
Start date
2021-11-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemic Acute Respiratory Insufficiency

Interventions

This is a non-blind randomized controlled trial. Patients from 1 month to 18 years of age admitted to the Pediatric Intensive Care Center (CTIP) of the Hospital das Clínicas da Faculdade de Medicina d
C08.618.846.688

Sponsors

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
1 Months to 18 Years

Inclusion criteria

Inclusion criteria: Patients 1 month to 18 years old; both genders; admitted to the Pediatric Intensive Care Center -CTIP - of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto, University of São Paulo -HCFMRP USP - with hypoxemic acute respiratory failure (PaO2/FiO2 less than or equal to 300 mmHg) and/or P -ARDS undergoing invasive mechanical ventilation for less than 24 hours

Exclusion criteria

Exclusion criteria: Chest circumference below 38 cm; tracheal tube without cuff; hemodynamic instability; chest imaging showing pneumomediastinal or non-pneumothorax drained; heart disease (congenital or acquired); recent thoracic surgery (< 2 months); skin lesions on the chest wall or drains that prevent the use of the strap to data acquisition; severe brain injury and/or intracranial hypertension; refusal of parents or guardians to consent to participate in the study

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the plasma concentration of IL-6 48h after the onset of study. It is expected to find significantly lower levels of IL-6 in plasma and tracheal aspirate of patients in the intervention group.

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactLeila Volpon

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

l.costavolpon@gmail.com+55(16)36021000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)